InsidersTradesSigma
Avadel Pharmaceuticals PLC: directors' dealings · United States · SEC (Form 4)
SEC:avadel-pharmaceuticals-plc-690412US·SEC (Form 4)
Explore the full management transaction log of Avadel Pharmaceuticals PLC, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 3 June 2022 (Acquisition). Among the most active insiders: Glass Geoffrey Michael. The full history is openly available.
8
Insider Decl.
0
Thresholds
€533,250
8 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Last declaration on 3 June 2022
Declarations8 total
Executives▲Purchase38SEC
€89,71445,000 shares@ €1.993649.8% of flow
ADSs
SEC:0001104659-22-068189:0·
Ideal exit: 25 Feb 2023 (T+270)
Executives▲Purchase40SEC
€90,38745,000 shares@ €2.008650.2% of flow
ADSs
SEC:0001104659-22-067598:0·
Ideal exit: 26 Feb 2023 (T+270)
Executives▲Purchase40SEC
€30,17915,000 shares@ €2.011946.8% of flow
ADSs
SEC:0001104659-22-067241:0·
Ideal exit: 25 Feb 2023 (T+270)
Executives▲Purchase41SEC
€14,90710,000 shares@ €1.4907100.0% of flow
ADSs
SEC:0001104659-22-066227:0·
Ideal exit: 21 Feb 2023 (T+270)
Executives▲Purchase41SEC
€78,72950,000 shares@ €1.5746100.0% of flow
ADSs
SEC:0001104659-22-066219:0·
Ideal exit: 21 Feb 2023 (T+270)
Executives▲Purchase38SEC
€34,23815,000 shares@ €2.282553.2% of flow
ADSs
SEC:0001104659-22-066222:0·
Ideal exit: 21 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 52SEC
€95,50050,000 shares@ €1.91100.0% of flow
ADSs
SEC:0001104659-22-066221:0·
Ideal exit: 21 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 49SEC
€99,59550,000 shares@ €1.9919100.0% of flow
ADSs
SEC:0001104659-22-066223:0·
Ideal exit: 21 Feb 2023 (T+270)
8 of 8 declarations